STAAR Surgical Co Revenue from Contract with Customer, Excluding Assessed Tax
STAAR Surgical Co (STAA) reported Revenue from Contract with Customer, Excluding Assessed Tax of $3.13 million for the 3-month period ending 2021-07-02, per its 10-Q filed 2021-08-04.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2021-08-04
- STAAR Surgical Co revenue from contract with customer, excluding assessed tax for the quarter ending 2021-07-02 was $3.13M, a 29.87% decline year-over-year.
- STAAR Surgical Co revenue from contract with customer, excluding assessed tax for the quarter ending 2021-04-02 was $4.25M, a 27.30% decline year-over-year.
- STAAR Surgical Co revenue from contract with customer, excluding assessed tax for the quarter ending 2021-01-01 was $6.15M, a 9.97% increase year-over-year.
- STAAR Surgical Co revenue from contract with customer, excluding assessed tax for the quarter ending 2020-10-02 was $5.59M, a 6.64% increase year-over-year.
- STAAR Surgical Co revenue from contract with customer, excluding assessed tax for fiscal 2021 was $22.05M, a 5.70% increase from fiscal 2020.
- STAAR Surgical Co revenue from contract with customer, excluding assessed tax for fiscal 2020 was $20.86M, a 8.78% decline from fiscal 2018.
- STAAR Surgical Co revenue from contract with customer, excluding assessed tax for fiscal 2018 was $22.87M, a 2.63% increase from fiscal 2017.
- STAAR Surgical Co revenue from contract with customer, excluding assessed tax for fiscal 2017 was $22.29M, a 4.44% decline from fiscal 2016.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2021-07-02 | $3.13M 10-Q · filed 2021-08-04 | $7.38M 10-Q · filed 2021-08-04 | $13.54M derived: sum of 3 quarters · filed 2021-08-04 | $19.12M derived: sum of 4 quarters · filed 2021-08-04 |
| 2021-04-02 | $4.25M 10-Q · filed 2021-05-05 | $10.40M derived: sum of 2 quarters · filed 2021-05-05 | $15.99M derived: sum of 3 quarters · filed 2021-05-05 | $20.46M derived: sum of 4 quarters · filed 2021-08-04 |
| 2021-01-01 | $6.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $11.74M derived: sum of 2 quarters · filed 2021-02-24 | $16.21M derived: sum of 3 quarters · filed 2021-08-04 | $22.05M 10-K · filed 2021-02-24 |
| 2020-10-02 | $5.59M 10-Q · filed 2020-11-04 | $10.05M derived: sum of 2 quarters · filed 2021-08-04 | $15.90M 10-Q · filed 2020-11-04 | $21.50M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-07-03 | $4.47M 10-Q · filed 2021-08-04 | $10.31M 10-Q · filed 2021-08-04 | $15.91M derived: sum of 3 quarters · filed 2021-08-04 | $21.15M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-04-03 | $5.85M 10-Q · filed 2021-05-05 | $11.44M derived: sum of 2 quarters · filed 2021-05-05 | $16.68M derived: sum of 3 quarters · filed 2021-05-05 | $21.91M derived: sum of 4 quarters · filed 2021-05-05 |
| 2020-01-03 | $5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $10.83M derived: sum of 2 quarters · filed 2021-02-24 | $16.07M derived: sum of 3 quarters · filed 2021-02-24 | $20.86M 10-K · filed 2021-02-24 |
| 2019-09-27 | $5.24M 10-Q · filed 2020-11-04 | $10.47M derived: sum of 2 quarters · filed 2020-11-04 | $15.27M 10-Q · filed 2020-11-04 | $20.24M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-28 | $5.23M 10-Q · filed 2020-08-05 | $10.03M 10-Q · filed 2020-08-05 | $15.00M derived: sum of 3 quarters · filed 2021-02-24 | $20.35M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-29 | $4.80M 10-Q · filed 2020-05-06 | $9.77M derived: sum of 2 quarters · filed 2021-02-24 | $15.12M derived: sum of 3 quarters · filed 2021-02-24 | $21.73M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-28 | $4.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $10.32M derived: sum of 2 quarters · filed 2021-02-24 | $16.94M derived: sum of 3 quarters · filed 2021-02-24 | $22.87M 10-K · filed 2021-02-24 |
| 2018-09-28 | $5.35M 10-Q · filed 2019-10-30 | $11.96M derived: sum of 2 quarters · filed 2019-10-30 | $17.90M 10-Q · filed 2019-10-30 | |
| 2018-06-29 | $6.61M 10-Q · filed 2019-07-31 | $12.55M 10-Q · filed 2019-07-31 | ||
| 2018-03-30 | $5.93M 10-Q · filed 2019-05-01 | |||
| 2017-12-29 | $22.29M 10-K · filed 2020-02-26 | |||
| 2016-12-30 | $23.32M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |